Literature DB >> 17404842

The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease.

A Claudio Cuello1, Martin A Bruno.   

Abstract

This short review discusses the arguments to consider the dismetabolism of the pathway responsible for both the maturation and degradation of NGF as the culprit of vulnerability of the forebrain cholinergic system to the Alzheimer's disease neuropathology. This summary includes information regarding a novel metabolic cascade converting Pro-NGF to mature NGF in the extracellular space and its ultimate degradation by a metalloprotease. It also describes how this pathway is altered in Alzheimer's disease with the consequential CNS accumulation of proNGF and impairment in the formation of NGF along with increased degradation of this key trophic factor. This metabolic scenario in Alzheimer's disease should result in the failure of NGF trophic support to forebrain cholinergic neurons and thus explaining the vulnerability of these neurons in this neurodegenerative condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404842     DOI: 10.1007/s11064-006-9270-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  17 in total

1.  Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.

Authors:  C Hock; A Maddalena; I Heuser; D Naber; W Oertel; H von der Kammer; M Wienrich; A Raschig; M Deng; J H Growdon; R M Nitsch
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.

Authors:  M Fahnestock; B Michalski; B Xu; M D Coughlin
Journal:  Mol Cell Neurosci       Date:  2001-08       Impact factor: 4.314

3.  Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury.

Authors:  A W Harrington; B Leiner; C Blechschmitt; J C Arevalo; R Lee; K Mörl; M Meyer; B L Hempstead; S O Yoon; K M Giehl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

Review 4.  Altered synaptic function in Alzheimer's disease.

Authors:  Karen F S Bell; A Claudio Cuello
Journal:  Eur J Pharmacol       Date:  2006-06-27       Impact factor: 4.432

5.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

6.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

7.  Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade.

Authors:  Martin A Bruno; A Claudio Cuello
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

8.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

Authors:  P J Whitehouse; D L Price; R G Struble; A W Clark; J T Coyle; M R Delon
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

9.  Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.

Authors:  S A Scott; E J Mufson; J A Weingartner; K A Skau; K A Crutcher
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

10.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

Authors:  R M Nitsch; B E Slack; R J Wurtman; J H Growdon
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

View more
  21 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

Review 2.  Mood, memory and movement: an age-related neurodegenerative complex?

Authors:  Ann-Charlotte Granholm; Heather Boger; Marina E Emborg
Journal:  Curr Aging Sci       Date:  2008-07

3.  Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

Authors:  Sylvia E Perez; Bin He; Nadeem Muhammad; Kwang-Jin Oh; Margaret Fahnestock; Milos D Ikonomovic; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2010-10-16       Impact factor: 5.996

Review 4.  Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.

Authors:  Donald E Moss; Ruth G Perez
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

Review 5.  The Molecular Effects of Environmental Enrichment on Alzheimer's Disease.

Authors:  Anthony Kin Yip Liew; Chuin Hau Teo; Tomoko Soga
Journal:  Mol Neurobiol       Date:  2022-09-09       Impact factor: 5.682

6.  proNGF inhibits neurogenesis and induces glial activation in adult mouse dentate gyrus.

Authors:  Jingjing Guo; Jianing Wang; Zhe Zhang; Jun Yan; Mingming Chen; Tao Pang; Luyong Zhang; Hong Liao
Journal:  Neurochem Res       Date:  2013-05-25       Impact factor: 3.996

Review 7.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

8.  Subtilisin-like proprotein convertase expression, localization, and activity in the human retina and optic nerve head.

Authors:  John A Fuller; Anne-Marie Brun-Zinkernagel; Abbot F Clark; Robert J Wordinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-01       Impact factor: 4.799

9.  AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.

Authors:  Satoshi Mizuno; Risa Iijima; Soichi Ogishima; Masataka Kikuchi; Yukiko Matsuoka; Samik Ghosh; Tadashi Miyamoto; Akinori Miyashita; Ryozo Kuwano; Hiroshi Tanaka
Journal:  BMC Syst Biol       Date:  2012-05-30

Review 10.  Neuroregeneration in neurodegenerative disorders.

Authors:  Ana M Enciu; Mihnea I Nicolescu; Catalin G Manole; Dafin F Mureşanu; Laurenţiu M Popescu; Bogdan O Popescu
Journal:  BMC Neurol       Date:  2011-06-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.